Lead Product(s) : Gatifloxacin
Therapeutic Area : Ophthalmology
Study Phase : Phase III
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Gatifloxacin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Eye Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 11, 2010
Lead Product(s) : Gatifloxacin
Therapeutic Area : Ophthalmology
Highest Development Status : Phase III
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
